Director, Head of Investigative Toxicology

Nurix•Brisbane, CA
•Onsite

About The Position

Nurix Therapeutics is seeking a Head of Investigative Toxicology to establish and lead its in-house in vitro toxicology testing capability. Reporting to the Senior Vice President, Nonclinical Toxicology, this hands-on, lab-based leadership role will build the assays, infrastructure, and mechanistic understanding needed to identify target- and modality-related safety liabilities earlier in discovery, reduce reliance on external CROs for early screening, and inform lead selection and optimization across targeted protein degrader programs. The role partners closely with Discovery Biology, Chemistry, DMPK, and Pharmacology. The position will establish and validate an in vitro toxicology platform, develop assays using primary and immortalized cell culture, hepatocyte and iPSC cardiomyocyte models, and set the technical roadmap for capabilities to build internally versus source through CRO partners. It will also lead day-to-day laboratory operations, including equipment, vendors, reagents, and data management. As the in vitro/investigative toxicology representative on discovery teams, the role will design and interpret mechanistic studies, including assessment of neosubstrate and off-target degradation risk. The Director will translate findings into risk assessments and recommendations for candidate selection and lead optimization, communicate with research leadership, and hire, mentor, and develop scientific staff as the function grows.

Requirements

  • PhD in Toxicology, Pharmacology, Molecular Biology, or a closely related life sciences discipline.
  • 10+ years of relevant nonclinical safety, investigative toxicology, or molecular/cellular toxicology experience in the pharmaceutical or biotechnology industry.
  • Direct, hands-on laboratory experience with in vitro and/or complex in vitro (MPS) model systems.
  • Demonstrated experience building, validating, and implementing new in vitro assay platforms or laboratory capabilities in an industry setting.
  • Strong working knowledge of mechanisms of drug-induced toxicity and in vitro tools used to investigate them, such as high-content imaging, primary and immortalized cell culture, hepatocyte/cardiomyocyte models, and genotoxicity assays.
  • Ability to translate in vitro data into actionable risk assessments and communicate findings clearly to cross-functional project teams and senior leadership.
  • Experience managing CRO relationships and evaluating build-versus-buy decisions for laboratory capabilities.

Nice To Haves

  • Postdoctoral training.
  • Experience with targeted protein degradation (TPD) or other novel small-molecule modalities, including neosubstrate/off-target degradation risk assessment.
  • Experience establishing or scaling a laboratory function within a growing, clinical-stage biotech.
  • Familiarity with New Approach Methodologies (NAMs) and organ-on-chip/microphysiological systems.
  • People management or mentoring experience.
  • Strong publication record in investigative or molecular toxicology.

Responsibilities

  • Design, establish, and validate an in-house in vitro toxicology testing platform, including assay selection, equipment procurement, protocol development, and standard operating procedures.
  • Develop and implement in vitro toxicology assays using primary and immortalized cell culture, hepatocyte models, and iPSC cardiomyocyte models to screen for cytotoxicity and off-target liabilities.
  • Define the technical roadmap and prioritize which in vitro assays to bring in-house versus source through CRO partners, balancing scientific value, cost, and speed.
  • Manage day-to-day laboratory operations, including equipment maintenance, vendor and reagent management, and data management systems.
  • Represent in vitro/investigative toxicology on discovery project teams and provide mechanistic insight into target- and modality-related safety findings.
  • Design and interpret investigative studies to elucidate toxicity mechanisms, including neosubstrate and off-target degradation risk for targeted protein degrader molecules.
  • Partner with DMPK, Pharmacology, and Discovery Biology to integrate in vitro toxicology data into candidate selection, structure-activity relationship (SAR), and lead optimization decisions.
  • Translate in vitro findings into risk assessments and clear recommendations for project teams and research leadership.
  • Hire, mentor, and develop scientific staff as the in vitro toxicology function grows.
  • Represent in vitro/investigative toxicology in Research Leadership meetings and contribute to the broader nonclinical safety strategy.
  • Foster a collaborative, science-driven culture consistent with Nurix’s values of rigor, creativity, and patient focus.

Stand Out From the Crowd

Upload your resume and get instant feedback on how well it matches this job.

Upload and Match Resume

What This Job Offers

Job Type

Full-time

Career Level

Director

Education Level

Ph.D. or professional degree

© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service